Real estate developer Pioneer Group has formed a UK partnership with King’s College London to build £180m (€210m) worth of life science facilities in London.
Pioneer Group said it has teamed up with the university to develop 95,000sqft of biotech and medtech facilities on the South Bank of London.
The partnership intends to renovate two sites on the South Bank of London, which are currently empty, to provide wet and dry laboratories, office and co-working space as well as access to critical equipment.
Pioneer Group will lead the design, development and operation of the facilities. Once complete, they will offer flexible space to aspiring companies.
Glenn Crocker, executive director at Pioneer Group said: “We are delighted to be working with King’s to house and help scale their exciting spin-out companies.
“We look forward to working with the wider team at King’s to help make the journey out of academia and into commercial reality as smooth and efficient as possible.”
Richard Trembath, a professor and SVP for health and life sciences at King’s College London and executive director of King’s Health Partners, said: “We are delighted to welcome Pioneer Group to the South Bank as they have a proven track record of providing specialist spaces where early-stage spin-outs can flourish.
“This is an important requirement as we enhance Innovation@King’s and an early pillar for the SC1 life sciences innovation district.”
SC1 is a collaboration between the King’s Health Partners, the London Boroughs of Lambeth and Southwark, and the Guy’s and St Thomas’ Foundation, dedicated to creating partnerships between researchers, clinicians and industry to develop innovative and life-changing technologies and therapies for our local and global communities.
To read the latest edition of the latest IPE Real Assets magazine click here.
